Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
- 1 January 1989
- journal article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 25 (1), 55-61
- https://doi.org/10.1007/bf00694339
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- Toxicological review of busulfan (Myleran)Mutation Research/Reviews in Genetic Toxicology, 1986
- THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATIONTransplantation, 1985
- Binding of busulfan to plasma proteins and blood cellsJournal of Pharmacy and Pharmacology, 1984
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideThe New England Journal of Medicine, 1983
- 715. Elimination–addition. Part I. Displacement of sulphonyl groups from diarylsulphonylalkanesJournal of the Chemical Society, 1962
- The mode of action of alkylating agents—III: The formation of 3-hydroxytetrahydrothiophene-1:1-dioxide from 1:4-dimethanesulphonyloxybutane (Myleran), S-β-l-alanyltetrahydrothiophenium mesylate, tetrahydro-thiophene and tetrahydrothiophene-1:1-dioxide in the rat, rabbit and mouseBiochemical Pharmacology, 1961
- Dimethanesulphonoxybutane (Myleran): Preliminary studies on distribution and metabolic fate in the ratBiochemical Pharmacology, 1959
- A physico-chemical investigation into the biological action of myleran and related sulphonic acid estersBiochemical Pharmacology, 1958